Atlas Trials

SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients

Clinical trial NCT05704088 · COMPLETED

Trial details

NCT number
NCT05704088
Sponsor
Mansoura University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SGLT2 INHIBITORSLupus NephritisBMD
Start date
2022-10-08
Primary completion
2024-01-08
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.